Loading...
SGLT2 inhibitors act from the extracellular surface of the cell membrane
SGLT2 inhibitors are a new class of drugs that have been recently developed to treat type II diabetes. They lower glucose levels by inhibiting the renal Na(+)/glucose cotransporter SGLT2, thereby increasing the amount of glucose excreted in the urine. Pharmacodynamics studies have raised questions a...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wiley Periodicals, Inc.
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4208661/ https://ncbi.nlm.nih.gov/pubmed/24973332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.12058 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|